Cargando…

3D and 4D Printing in the Fight against Breast Cancer

Breast cancer is the second most common cancer worldwide, characterized by a high incidence and mortality rate. Despite the advances achieved in cancer management, improvements in the quality of life of breast cancer survivors are urgent. Moreover, considering the heterogeneity that characterizes tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Moroni, Sofia, Casettari, Luca, Lamprou, Dimitrios A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394292/
https://www.ncbi.nlm.nih.gov/pubmed/35892465
http://dx.doi.org/10.3390/bios12080568
_version_ 1784771456848101376
author Moroni, Sofia
Casettari, Luca
Lamprou, Dimitrios A.
author_facet Moroni, Sofia
Casettari, Luca
Lamprou, Dimitrios A.
author_sort Moroni, Sofia
collection PubMed
description Breast cancer is the second most common cancer worldwide, characterized by a high incidence and mortality rate. Despite the advances achieved in cancer management, improvements in the quality of life of breast cancer survivors are urgent. Moreover, considering the heterogeneity that characterizes tumors and patients, focusing on individuality is fundamental. In this context, 3D printing (3DP) and 4D printing (4DP) techniques allow for a patient-centered approach. At present, 3DP applications against breast cancer are focused on three main aspects: treatment, tissue regeneration, and recovery of the physical appearance. Scaffolds, drug-loaded implants, and prosthetics have been successfully manufactured; however, some challenges must be overcome to shift to clinical practice. The introduction of the fourth dimension has led to an increase in the degree of complexity and customization possibilities. However, 4DP is still in the early stages; thus, research is needed to prove its feasibility in healthcare applications. This review article provides an overview of current approaches for breast cancer management, including standard treatments and breast reconstruction strategies. The benefits and limitations of 3DP and 4DP technologies are discussed, as well as their application in the fight against breast cancer. Future perspectives and challenges are outlined to encourage and promote AM technologies in real-world practice.
format Online
Article
Text
id pubmed-9394292
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93942922022-08-23 3D and 4D Printing in the Fight against Breast Cancer Moroni, Sofia Casettari, Luca Lamprou, Dimitrios A. Biosensors (Basel) Review Breast cancer is the second most common cancer worldwide, characterized by a high incidence and mortality rate. Despite the advances achieved in cancer management, improvements in the quality of life of breast cancer survivors are urgent. Moreover, considering the heterogeneity that characterizes tumors and patients, focusing on individuality is fundamental. In this context, 3D printing (3DP) and 4D printing (4DP) techniques allow for a patient-centered approach. At present, 3DP applications against breast cancer are focused on three main aspects: treatment, tissue regeneration, and recovery of the physical appearance. Scaffolds, drug-loaded implants, and prosthetics have been successfully manufactured; however, some challenges must be overcome to shift to clinical practice. The introduction of the fourth dimension has led to an increase in the degree of complexity and customization possibilities. However, 4DP is still in the early stages; thus, research is needed to prove its feasibility in healthcare applications. This review article provides an overview of current approaches for breast cancer management, including standard treatments and breast reconstruction strategies. The benefits and limitations of 3DP and 4DP technologies are discussed, as well as their application in the fight against breast cancer. Future perspectives and challenges are outlined to encourage and promote AM technologies in real-world practice. MDPI 2022-07-26 /pmc/articles/PMC9394292/ /pubmed/35892465 http://dx.doi.org/10.3390/bios12080568 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Moroni, Sofia
Casettari, Luca
Lamprou, Dimitrios A.
3D and 4D Printing in the Fight against Breast Cancer
title 3D and 4D Printing in the Fight against Breast Cancer
title_full 3D and 4D Printing in the Fight against Breast Cancer
title_fullStr 3D and 4D Printing in the Fight against Breast Cancer
title_full_unstemmed 3D and 4D Printing in the Fight against Breast Cancer
title_short 3D and 4D Printing in the Fight against Breast Cancer
title_sort 3d and 4d printing in the fight against breast cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394292/
https://www.ncbi.nlm.nih.gov/pubmed/35892465
http://dx.doi.org/10.3390/bios12080568
work_keys_str_mv AT moronisofia 3dand4dprintinginthefightagainstbreastcancer
AT casettariluca 3dand4dprintinginthefightagainstbreastcancer
AT lamproudimitriosa 3dand4dprintinginthefightagainstbreastcancer